Fifth Third Bancorp
IONS icon

Fifth Third Bancorp’s Ionis Pharmaceuticals IONS Stock Holding History

Fifth Third Bancorp’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$827K Buy
11,011
+3,123
+40% +$246K ﹤0.01% 1747
2025
Q4 		$624K Sell
7,888
-56
-0.7% -$4.22K ﹤0.01% 709
2025
Q3 		$520K Buy
7,944
+346
+5% +$16.9K ﹤0.01% 803
2025
Q2 		$300K Sell
7,598
-2,391
-24% -$78.2K ﹤0.01% 890
2025
Q1 		$301K Buy
9,989
+458
+5% +$15K ﹤0.01% 868
2024
Q4 		$333K Sell
9,531
-41
-0.4% -$1.53K ﹤0.01% 847
2024
Q3 		$383K Buy
9,572
+110
+1% +$5.12K ﹤0.01% 837
2024
Q2 		$451K Sell
9,462
-171
-2% -$7.01K ﹤0.01% 776
2024
Q1 		$418K Buy
9,633
+351
+4% +$16.7K ﹤0.01% 812
2023
Q4 		$470K Buy
9,282
+6,782
+271% +$325K ﹤0.01% 765
2023
Q3 		$113K Hold
2,500
– – ﹤0.01% 1101
2023
Q2 		$103K Sell
2,500
-500
-17% -$19.2K ﹤0.01% 1138
2023
Q1 		$107K Buy
3,000
+500
+20% +$18.8K ﹤0.01% 1175
2022
Q4 		$94.4K Hold
2,500
– – ﹤0.01% 1145
2022
Q3 		$111K Hold
2,500
– – ﹤0.01% 1082
2022
Q2 		$93K Sell
2,500
-214
-8% -$8.07K ﹤0.01% 1161
2022
Q1 		$101K Buy
2,714
+88
+3% +$2.88K ﹤0.01% 1191
2021
Q4 		$80K Hold
2,626
– – ﹤0.01% 1311
2021
Q3 		$88K Buy
2,626
+72
+3% +$2.71K ﹤0.01% 1220
2021
Q2 		$102K Sell
2,554
-7,004
-73% -$274K ﹤0.01% 1182
2021
Q1 		$430K Sell
9,558
-100
-1% -$5.58K ﹤0.01% 731
2020
Q4 		$546K Sell
9,658
-1,404
-13% -$70K ﹤0.01% 651
2020
Q3 		$525K Sell
11,062
-126
-1% -$7K ﹤0.01% 629
2020
Q2 		$660K Hold
11,188
– – ﹤0.01% 583
2020
Q1 		$529K Buy
11,188
+806
+8% +$44.9K ﹤0.01% 585
2019
Q4 		$627K Buy
10,382
+3,100
+43% +$185K ﹤0.01% 608
2019
Q3 		$436K Sell
7,282
-152
-2% -$9.91K ﹤0.01% 669
2019
Q2 		$478K Buy
7,434
+440
+6% +$31.1K ﹤0.01% 633
2019
Q1 		$568K Sell
6,994
-77
-1% -$4.97K ﹤0.01% 584
2018
Q4 		$382K Sell
7,071
-47
-0.7% -$2.4K ﹤0.01% 690
2018
Q3 		$367K Sell
7,118
-524
-7% -$24.6K ﹤0.01% 749
2018
Q2 		$318K Buy
7,642
+571
+8% +$25.3K ﹤0.01% 778
2018
Q1 		$312K Buy
7,071
+6,882
+3,641% +$350K ﹤0.01% 771
2017
Q4 		$10K Hold
189
– – ﹤0.01% 1826
2017
Q3 		$10K Hold
189
– – ﹤0.01% 1771
2017
Q2 		$10K Hold
189
– – ﹤0.01% 1718
2017
Q1 		$8K Hold
189
– – ﹤0.01% 1761
2016
Q4 		$9K Hold
189
– – ﹤0.01% 1820
2016
Q3 		$7K Buy
189
+54
+40% +$1.69K ﹤0.01% 1912
2016
Q2 		$3K Hold
135
– – ﹤0.01% 2059
2016
Q1 		$5K Sell
135
-60
-31% -$2.44K ﹤0.01% 2021
2015
Q4 		$12K Sell
195
-131
-40% -$7.07K ﹤0.01% 1872
2015
Q3 		$13K Sell
326
-721
-69% -$37.3K ﹤0.01% 1922
2015
Q2 		$60K Hold
1,047
– – ﹤0.01% 1374
2015
Q1 		$67K Buy
1,047
+889
+563% +$60.3K ﹤0.01% 1323
2014
Q4 		$10K Sell
158
-3,343
-95% -$165K ﹤0.01% 1931
2014
Q3 		$136K Buy
3,501
+1,331
+61% +$47.2K ﹤0.01% 1069
2014
Q2 		$75K Sell
2,170
-697
-24% -$21.9K ﹤0.01% 1274
2014
Q1 		$124K Buy
2,867
+2,732
+2,024% +$132K ﹤0.01% 1104
2013
Q4 		$5K Buy
+135
New +$4.81K ﹤0.01% 1978

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's IONS Position: Q1 2026 in Review

Fifth Third Bancorp increased its Ionis Pharmaceuticals (IONS) stake by 40% in Q1 2026, buying an estimated $246K and bringing the position to 11,011 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Fifth Third Bancorp first reported a position in IONS in Q4 2013 and has held it in 50 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Fifth Third Bancorp held 11,011 shares of Ionis Pharmaceuticals worth $827K as of Q1 2026.
  • Fifth Third Bancorp bought 3,123 Ionis Pharmaceuticals shares in Q1 2026, an estimated $246K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1747 holding.
  • Fifth Third Bancorp first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.